Resultados de la búsqueda 431-440 of 13020 for Open-angle glaucoma

  1. Radiología - Ensayos clínicos - Mayo Clinic

    The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer.

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    ... angle at maturity in a larger multicenter study. The ultimate goal of this research project will be to validate this new predictive model and finally ...

  3. Radiología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in combination with ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    ... angle at maturity in a larger multicenter study. The ultimate goal of this research project will be to validate this new predictive model and finally ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK) ...

  8. Radiología - Ensayos clínicos - Mayo Clinic

    The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with breast cancer.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK) ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK) ...